SCHEMBL30946402

SCHEMBL30946402

FC(F)(F)c1ccc(N=C(c2ccccc2)c2ccccc2)cc1-n1ncc(Cl)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.34
▸ ESR2 Q92731 3/20 0.34
▸ HTR3E A5X5Y0 1/20 0.34
▸ HTR3B O95264 1/20 0.34
▸ HTR3A P46098 1/20 0.34
▸ HTR3D Q70Z44 1/20 0.34
▸ HTR3C Q8WXA8 1/20 0.34
▸ LMNA P02545 3/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ NTRK1 P04629 1/20 0.33
▸ KMT2A Q03164 3/20 0.32
▸ HPGD P15428 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31284998 0.77 CYP1A2 (0.35) ESR1ESR2NPSR1CYP1A2CYP2C9
SCHEMBL30946425 0.72 NT5E (0.35) —
SCHEMBL30946489 0.72 MAPT (0.41) SMN1; SMN2MAPTKDM4ENPSR1KMT2A
SCHEMBL31284304 0.71 NOTUM (0.42) ESR1ESR2NTRK1
SCHEMBL6135928 0.71 ESR1 (0.44) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL8586278 0.67 MAPT (0.50) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL31284106 0.67 KAT6A (0.35) ESR1ESR2NPSR1CYP1A2CYP2C9
SCHEMBL21630253 0.66 HSD11B1 (0.35) ESR1ESR2LMNASMN1; SMN2MAPT
SCHEMBL20689111 0.65 ESR1 (0.38) ESR1ESR2LMNAMAPTKDM4E
SCHEMBL31284651 0.65 ESR1 (0.36) ESR1ESR2NPSR1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743085-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics, Inc. (US) 2026-05-20 — — EP disclosed
EP-4634161-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics Inc. (US) 2025-10-22 — — EP disclosed
WO-2025019357-A2 COMPOUNDS, COMPOSITIONS, AND METHODS NICO THERAPEUTICS, INC. (US) 2025-01-23 — — WO disclosed
WO-2024130166-A2 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-06-20 — — WO disclosed
Send feedback